Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic Nanomedicine
Yan Zou, Yanjie Liu, Zhipeng Yang, et al.
Advanced Materials (2018) Vol. 30, Iss. 51
Closed Access | Times Cited: 182

Showing 1-25 of 182 citing articles:

The blood–brain barrier: Structure, regulation and drug delivery
Di Wu, Qi Chen, Xiaojie Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 615
Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranostics
Wei Tang, Wenpei Fan, Joseph Lau, et al.
Chemical Society Reviews (2019) Vol. 48, Iss. 11, pp. 2967-3014
Closed Access | Times Cited: 505
Targeting drugs to tumours using cell membrane-coated nanoparticles
Ronnie H. Fang, Weiwei Gao, Liangfang Zhang
Nature Reviews Clinical Oncology (2022) Vol. 20, Iss. 1, pp. 33-48
Closed Access | Times Cited: 481
Supramolecular cancer nanotheranostics
Jiong Zhou, Lang Rao, Guocan Yu, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 4, pp. 2839-2891
Closed Access | Times Cited: 345
Ligand‐Installed Nanocarriers toward Precision Therapy
Peng Mi, Horacio Cabral, Kazunori Kataoka
Advanced Materials (2019) Vol. 32, Iss. 13
Closed Access | Times Cited: 302
Nanocarrier-based drug combination therapy for glioblastoma
Mengnan Zhao, Demian van Straten, Marike L. D. Broekman, et al.
Theranostics (2020) Vol. 10, Iss. 3, pp. 1355-1372
Open Access | Times Cited: 294
Targeted exosome‐encapsulated erastin induced ferroptosis in triple negative breast cancer cells
Mengyu Yu, Chengcheng Gai, Zihaoran Li, et al.
Cancer Science (2019) Vol. 110, Iss. 10, pp. 3173-3182
Open Access | Times Cited: 286
Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery
Huaiji Wang, Ying Liu, Ruiqing He, et al.
Biomaterials Science (2019) Vol. 8, Iss. 2, pp. 552-568
Closed Access | Times Cited: 248
Natural-Killer-Cell-Inspired Nanorobots with Aggregation-Induced Emission Characteristics for Near-Infrared-II Fluorescence-Guided Glioma Theranostics
Guanjun Deng, Xinghua Peng, Zhihong Sun, et al.
ACS Nano (2020) Vol. 14, Iss. 9, pp. 11452-11462
Closed Access | Times Cited: 209
ROS‐Responsive Polymeric siRNA Nanomedicine Stabilized by Triple Interactions for the Robust Glioblastoma Combinational RNAi Therapy
Meng Zheng, Yuanyuan Liu, Yibin Wang, et al.
Advanced Materials (2019) Vol. 31, Iss. 37
Closed Access | Times Cited: 194
Camouflaging Nanoparticles with Brain Metastatic Tumor Cell Membranes: A New Strategy to Traverse Blood–Brain Barrier for Imaging and Therapy of Brain Tumors
Caixia Wang, Bo Wu, Yuting Wu, et al.
Advanced Functional Materials (2020) Vol. 30, Iss. 14
Closed Access | Times Cited: 193
Recent Advances of Cell Membrane‐Coated Nanomaterials for Biomedical Applications
Wen‐Long Liu, Mei‐Zhen Zou, Si‐Yong Qin, et al.
Advanced Functional Materials (2020) Vol. 30, Iss. 39
Closed Access | Times Cited: 177
Artificial intelligence aids in development of nanomedicines for cancer management
Ping Tan, Xiaoting Chen, Hu Zhang, et al.
Seminars in Cancer Biology (2023) Vol. 89, pp. 61-75
Closed Access | Times Cited: 151
Biologically modified nanoparticles as theranostic bionanomaterials
Jielai Yang, Xingcai Zhang, Chuang LIU, et al.
Progress in Materials Science (2020) Vol. 118, pp. 100768-100768
Closed Access | Times Cited: 145
Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment
Yan Zou, Xinhong Sun, Yibin Wang, et al.
Advanced Materials (2020) Vol. 32, Iss. 24
Closed Access | Times Cited: 141
Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier
Jia Li, Meng Zheng, Olga Shimoni, et al.
Advanced Science (2021) Vol. 8, Iss. 16
Open Access | Times Cited: 133
Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome‐Conjugated Magnetic Nanoparticles for Glioblastoma Therapy
Boyan Li, Xin Chen, Wei Qiu, et al.
Advanced Science (2022) Vol. 9, Iss. 17
Open Access | Times Cited: 127
Exosomes based strategies for brain drug delivery
Fawad Ur Rehman, Yang Liu, Meng Zheng, et al.
Biomaterials (2022) Vol. 293, pp. 121949-121949
Closed Access | Times Cited: 120
Brain Co‐Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy
Yan Zou, Yibin Wang, Sen Xu, et al.
Advanced Materials (2022) Vol. 34, Iss. 33
Closed Access | Times Cited: 116
Brain co‐delivery of first‐line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapy
Yanjie Liu, Wendie Wang, Dongya Zhang, et al.
Exploration (2022) Vol. 2, Iss. 4
Open Access | Times Cited: 92
Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment
Yan Zou, Yajing Sun, Yibin Wang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 85
Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy
Wenya He, Xiaozhe Li, Marco Morsch, et al.
ACS Nano (2022) Vol. 16, Iss. 4, pp. 6293-6308
Closed Access | Times Cited: 81
Engineering a HEK-293T exosome-based delivery platform for efficient tumor-targeting chemotherapy/internal irradiation combination therapy
Congcong Wang, Ning Li, Yutian Li, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 77
Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma
Muhammad Ismail, Wen Yang, Yanfei Li, et al.
Biomaterials (2022) Vol. 287, pp. 121608-121608
Closed Access | Times Cited: 77
Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy
Fawad Ur Rehman, Yang Liu, Qingshan Yang, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 696-708
Closed Access | Times Cited: 73
Page 1 - Next Page

Scroll to top